Pfizer and BioNTech could seek emergency use authorization from the US Food and Drug Administration for a second booster shot of their Covid-19 vaccine for people 65 and older as soon as Tuesday, in news first reported by The Washington Post.

(SOURCE) https://www.cnn.com/2022/03/15/health/pfizer-fourth-shot-seniors/index.html